Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AccuLine logo — Preventing The Next Heart Attack

AccuLine

Preventing The Next Heart Attack

Founded 2022 Israel Israel 11 employees Seed Total: $5.75M AI, Health Care +2

General Information

Company Name AccuLine
Founded Year 2022
Location Israel Israel
Employees 11
Industries AI, Health Care, Medical Devices +1
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with AccuLine. To contact AccuLine, visit acculine-medical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AccuLine compare?

A PDF of AccuLine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AccuLine soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AccuLine

AccuLine is a pioneering health care startup with the compelling slogan, Preventing The Next Heart Attack. Founded in 2022 in Israel, AccuLine's mission is to save lives worldwide by preventing heart attacks. The company is in the process of developing CORA, a non-invasive, accurate, and cost-effective exam for the early detection of CAD. This user-friendly exam aims to replace the inaccurate, time-consuming, and labor-intensive ergometry exams, addressing the limitations of existing tools in accuracy, invasiveness, and cost. AccuLine has garnered significant support, having received a $150.00K Grant investment on 01 May 2024, with Google being one of the key investors. Moreover, AccuLine has also secured grants from Google and the Israeli Innovation Authority. Notably, among its shareholders are esteemed entities such as Mayo Clinic, eHealth Ventures, and Maccabi Healthcare Services. With its innovative approach and influential backers, AccuLine is well-positioned to make a significant impact in the field of preventive cardiac care.

Business keywords: cardiovascular disease, early detection, non-invasive, vital signs, digital health, startup, investment, grant funding, Mayo Clinic, Israeli Innovation Authority, eHealth Ventures, Maccabi Healthcare Services, innovative medical devices

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $150.00K 1
Google
Google
01 May 2024
Seed Round $3.50M 3
eHealth Ventures Mayo Clinic Ventures
eHealth Ventures, Mayo Clinic Ventures +1
01 May 2024
Grant $600.00K 1
Israel Innovation Authority
01 Mar 2024
Convertible Note $200.00K 1
Mayo Clinic
Mayo Clinic
02 Sep 2023
Grant $900.00K 1
Israel Innovation Authority
01 Mar 2022
Pre Seed Round $400.00K 2
eHealth Ventures
eHealth Ventures, Maccabi Fund
01 Mar 2022

AccuLine Alternatives & Competitors

View All Alternatives
AccuLine vs
Eupnea
Eupnea Norway

Intelligent respirator monitoring Every breath counts

8 employees
Health Care, Medical Devices
AccuLine vs
Aireen
Aireen Czech Republic

AI-driven precision screening for better healthcare outcomes—early detection, improved efficiency, a...

Seed
21 employees
AI, Health Care
AccuLine vs
MedicubeX Ltd
MedicubeX Ltd Finland

Monitor vital signs and CVD risk factors, and connect with a remote video appointment for preventive...

Debt Financing
10 employees
Health Care, Medical Devices
View all alternatives

FAQ About AccuLine

Preventing The Next Heart Attack
AccuLine was founded in 2022.
AccuLine is headquartered in Israel.
AccuLine operates in AI, Health Care, Medical Devices and Machine Learning. Its work centres on cardiovascular disease, early detection, non-invasive and vital signs.
AccuLine has approximately 11 employees.
AccuLine has completed 6 funding rounds, raising a total of $5.75M. The latest funding stage is Seed.
Top alternatives and competitors to AccuLine include Eupnea, Aireen, MedicubeX Ltd, VPG Medical, Inc., Sensydia Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AccuLine and Eupnea are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AccuLine, https://bouncewatch.com/company/acculine, updated 24 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes